MARKET

ASND

ASND

Ascendis Pharma
NASDAQ
134.38
+0.37
+0.28%
After Hours: 134.38 0 0.00% 16:00 07/25 EDT
OPEN
133.97
PREV CLOSE
134.01
HIGH
136.41
LOW
133.91
VOLUME
177.69K
TURNOVER
0
52 WEEK HIGH
161.00
52 WEEK LOW
85.29
MARKET CAP
7.82B
P/E (TTM)
-14.0200
1D
5D
1M
3M
1Y
5Y
1D
Morgan Stanley Remains a Hold on Ascendis Pharma (ASND)
TipRanks · 4d ago
Weekly Report: what happened at ASND last week (0715-0719)?
Weekly Report · 4d ago
Ascendis Pharma A/S' (NASDAQ:ASND) Share Price Could Signal Some Risk
Ascendantis Pharma A/S (NASDAQ:ASND) has a price-to-sales ratio of 21.7x. The company is trading at a much higher price to sales ratio than the rest of the biotechnology industry. The high P/S is a concern as the company's revenues are predicted to grow at a slower rate than the industry.
Simply Wall St · 6d ago
$1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 10 years by 43.24%. The company has an average annual return of 54.04% on an annualized basis. If an investor bought $1000 of ASND stock 10 years ago, it would be worth $74,821.
Benzinga · 07/18 17:00
Artisan International Fund Q2 2024 Commentary
With inflation slowing in many countries, equity markets saw modest returns in Q2. Stocks in Asia ex-Japan and North America performed particularly well. Growth outperformed value stocks in most regions. The portfolio fell short of the MSCI EAFE Index and MSCi All Country World ex USA Index.
Seeking Alpha · 07/16 13:45
Morgan Stanley Remains a Hold on Ascendis Pharma (ASND)
TipRanks · 07/15 12:25
Weekly Report: what happened at ASND last week (0708-0712)?
Weekly Report · 07/15 09:26
Wells Fargo Keeps Their Buy Rating on Ascendis Pharma (ASND)
TipRanks · 07/11 10:49
More
About ASND
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Webull offers Ascendis Pharma A/S (ADR) stock information, including NASDAQ: ASND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASND stock methods without spending real money on the virtual paper trading platform.